Key result
Novel dual-diameter transcatheter mitral valve demonstrates successful hydrodynamic function in bench testing.
Why the study?
Elderly patients frequently suffer from secondary mitral regurgitation but are often ineligible for surgical valve replacement due to high procedural risks.
This bioengineering study demonstrates the initial structural feasibility of a novel single-component transcatheter mitral valve design intended to address existing deliverability and anchoring challenges.
Initial feasibility of a single-component mitral stent supports iterative engineering; leaves open in vivo durability and clinical deliverability.
Background: The development of transcatheter mitral valves (TMVs) represents a major advancement in cardiology, driven in part by the growing elderly population. Elderly patients frequently suffer from secondary mitral regurgitation but are often ineligible for surgical valve replacement due to high procedural risks. This study aimed to develop a self-expanding TMV stent fabricated from a single nitinol tube, featuring two distinct central zones: a smaller-diameter valve-containing segment and a larger-diameter anchoring segment for the mitral annulus. Methods: We used the COMSOL Multiphysics 6.0 software package for biotechnical engineering. Prototypes of stents and valves were manufactured in five sizes following a 22 Fr delivery system compatibility assessment and pulsatile-flow testing. Results: We bioengineered a novel stent design with an integrated porcine pericardial valve. The stents were laser-cut from nitinol tubes (4.5 mm outer diameter, 0.45 mm wall thickness) and heat-treated to achieve spatial configurations compatible with fibrous ring diameters of 40, 42, 44, 46, and 48 mm. Pericardial leaflets and coverings were then mounted onto the stents. The resulting valves were successfully loaded into a 24 Fr delivery system and exhibited proper opening and closing function under pulsatile-flow testing. Conclusions: Our findings confirm the feasibility of a single-component, dual-diameter TMV stent, offering a promising solution for high-risk patients with mitral regurgitation.
No takes yet. Share an insight, caveat, or question.
I.Yu. Zhuravleva (2025) studied Mitral regurgitation (n=5). Novel self-expanding transcatheter mitral valve stent with dual annulus/valve diameter was evaluated on Delivery system compatibility and proper opening and closing function under pulsatile-flow testing. A novel single-component, dual-diameter transcatheter mitral valve stent with an integrated porcine pericardial valve was successfully fabricated and exhibited proper function under pulsatile-flow testing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: